These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2806381

  • 1. The reversible MAO inhibitor, brofaromine, inhibits serotonin uptake in vivo.
    Waldmeier PC, Stöcklin K.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):197-204. PubMed ID: 2806381
    [Abstract] [Full Text] [Related]

  • 2. Binding of [3H]brofaromine to monoamine oxidase A in vivo: displacement by clorgyline and moclobemide.
    Waldmeier PC, Stöcklin K.
    Eur J Pharmacol; 1990 May 16; 180(2-3):297-304. PubMed ID: 2365007
    [Abstract] [Full Text] [Related]

  • 3. Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine.
    Waldmeier PC.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar 16; 17(2):183-98. PubMed ID: 8430214
    [Abstract] [Full Text] [Related]

  • 4. Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine.
    Waldmeier PC, Graf T, Germer M, Feldtrauer JJ, Howald H.
    Biol Psychiatry; 1993 Mar 01; 33(5):373-9. PubMed ID: 8471696
    [Abstract] [Full Text] [Related]

  • 5. Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.
    Da Prada M, Kettler R, Keller HH, Burkard WP, Haefely WE.
    J Neural Transm Suppl; 1989 Mar 01; 28():5-20. PubMed ID: 2677242
    [Abstract] [Full Text] [Related]

  • 6. The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats.
    Celada P, Bel N, Artigas F.
    J Neural Transm Suppl; 1994 Mar 01; 41():357-63. PubMed ID: 7931251
    [Abstract] [Full Text] [Related]

  • 7. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ, Allison K, Holt A, Greenshaw AJ, Baker GB.
    J Affect Disord; 2000 May 01; 58(2):135-44. PubMed ID: 10781703
    [Abstract] [Full Text] [Related]

  • 8. Brofaromine: a monoamine oxidase-A and serotonin uptake inhibitor.
    Waldmeier PC, Glatt A, Jaekel J, Bittiger H.
    Clin Neuropharmacol; 1993 May 01; 16 Suppl 2():S19-24. PubMed ID: 8313393
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regional action of brofaromine on rat brain MAO-A and MAO-B.
    Gerardy J, Dresse A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct 01; 22(7):1141-55. PubMed ID: 9829294
    [Abstract] [Full Text] [Related]

  • 12. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R, Da Prada M, Burkard WP.
    Acta Psychiatr Scand Suppl; 1990 Oct 01; 360():101-2. PubMed ID: 2248058
    [Abstract] [Full Text] [Related]

  • 13. CGP 4718 A, a new potential antidepressant with a dual mode of action.
    Waldmeier PC, Tipton KF, Bernasconi R, Felner AE, Baumann PA, Maitre L.
    Eur J Pharmacol; 1984 Dec 15; 107(1):79-89. PubMed ID: 6526072
    [Abstract] [Full Text] [Related]

  • 14. Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.
    Kovachich GB, Aronson CE, Brunswick DJ, Frazer A.
    Brain Res; 1988 Jun 28; 454(1-2):78-88. PubMed ID: 2970277
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors.
    Fletcher PJ, Yu PH.
    Psychopharmacology (Berl); 1989 Jun 28; 98(2):265-8. PubMed ID: 2502797
    [Abstract] [Full Text] [Related]

  • 16. Brofaromine, a drug inhibiting MAO-A and 5-HT uptake.
    Waldmeier PC, Feldtrauer JJ, Graf T, Howald H.
    Clin Neuropharmacol; 1992 Jun 28; 15 Suppl 1 Pt A():341A-342A. PubMed ID: 1498863
    [No Abstract] [Full Text] [Related]

  • 17. Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography.
    Kovachich GB, Aronson CE, Brunswick DJ.
    Neuropsychopharmacology; 1992 Dec 28; 7(4):317-24. PubMed ID: 1476595
    [Abstract] [Full Text] [Related]

  • 18. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
    Marcusson J, Eriksson K.
    J Neurochem; 1988 Nov 28; 51(5):1477-81. PubMed ID: 2971784
    [Abstract] [Full Text] [Related]

  • 19. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO, Bergström M, Eriksson K, Ross SB.
    J Neurochem; 1988 Jun 28; 50(6):1783-90. PubMed ID: 2967349
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec 28; 336(6):591-6. PubMed ID: 2965308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.